Pharmacist-directed anticoagulation service can impact patient satisfaction
As hospitals look for ways to improve patient satisfaction and boost their Medicare reimbursement, a Henry Ford Hospital study found that an inpatient pharmacist-directed anticoagulation service (PDAS) might be an unexpected ...
Health
May 10, 2013 |
not rated yet |
0
Operating without interrupting warfarin reduces risk of bleeding after cardiac device surgery
A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current ...
Cardiology
May 09, 2013 |
not rated yet |
0
Scientists develop antidote to new anticoagulants
(Medical Xpress)—Anticoagulants have saved the lives of those at risk for heart attack or stroke. However, because they prevent blood clotting, they can be dangerous to patients who suffer traumatic injuries or who require ...
Medical research
Mar 05, 2013 |
5 / 5 (2) |
0
|
Kcentra approved to stop severe bleeding in heart patients
(HealthDay)—Kcentra (prothrombin complex concentrate, human) has been approved by the U.S. Food and Drug Administration to treat severe acute bleeding in adults after administration of the anti-clotting drug warfarin and ...
Medications
Apr 30, 2013 |
not rated yet |
0
Apixaban superior to warfarin for preventing stroke, reducing bleeding and saving lives
A large-scale trial finds that apixaban, a new anticoagulant drug, is superior to the standard drug warfarin for preventing stroke and systemic embolism in patients with atrial fibrillation. Moreover, apixaban results in ...
Medical research
Aug 28, 2011 |
5 / 5 (3) |
1
|
Two new papers on dabigatran etexilate (Pradaxa) and intracranial hemorrhage
The Journal of Neurosurgery Publishing Group is pleased to announce publication of two new studies on dabigatran etexilate (Pradaxa®) and intracranial hemorrhage: one in the Journal of Neurosurgery and the other in Neur ...
Surgery
May 01, 2013 |
not rated yet |
0
New blood thinner beats older drug for vein clots
(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, ...
Medications
Feb 20, 2013 |
4 / 5 (1) |
0
|
Newly approved blood thinner may increase susceptibility to some viral infections
A study led by researchers at the University of North Carolina indicates that a newly approved blood thinner that blocks a key component of the human blood clotting system may increase the risk and severity of certain viral ...
Medical research
Apr 01, 2013 |
not rated yet |
0
|
Undertreatment of common heart condition persists despite rapid adoption of novel therapies
A novel blood thinner recently approved by the FDA, dabigatran (Pradaxa), has been rapidly adopted into clinical practice, yet thus far has had little impact on improving treatment rates for atrial fibrillation. This is according ...
Cardiology
Sep 21, 2012 |
not rated yet |
0
Do blood thinners + stroke treatment = danger? Study indicates the risk is low
Millions of Americans take aspirin or other drugs every day to reduce their risk of heart attacks or other problems caused by blood clots.
Cardiology
Mar 13, 2013 |
not rated yet |
0
|
Resuming warfarin after gastrointestinal tract bleeding linked with lower risk for thrombosis, death
A study of patients treated with the anticoagulant medication warfarin suggests that resuming warfarin therapy after an episode of gastrointestinal tract bleeding was associated with lower risk for thrombosis (blood clot) ...
Diseases, Conditions, Syndromes
Sep 17, 2012 |
not rated yet |
0
Chronic kidney disease increases stroke risk in A-fib
(HealthDay) -- Patients with atrial fibrillation who have chronic kidney disease are at higher risk of stroke or systemic thromboembolism and bleeding, according to a study published in the Aug. 16 issue ...
Diseases, Conditions, Syndromes
Aug 16, 2012 |
not rated yet |
0
Rivaroxaban has less risk of brain bleeding in patients at high risk for stroke
For patients with a type of irregular heart beat called atrial fibrillation (AF), a new anti-clotting drug might be better at preventing clot-related strokes while minimizing the risk of causing a bleeding stroke. The research ...
Cardiology
Feb 02, 2012 |
not rated yet |
0
New blood thinner may lower chances of clots in high-risk heart patients: FDA
(HealthDay) -- The new blood thinner Xarelto appears to lower the chances of potentially fatal blood clots in high-risk heart patients, a U.S. Food and Drug Administration review has found.
Medications
May 21, 2012 |
not rated yet |
0
Aspirin effective in preventing clots following joint replacement surgery
Research from the Rothman Institute at Jefferson has shown aspirin to be just as effective as warfarin in preventing clots, specifically pulmonary emboli, life-threatening blood clots that can develop in the arteries of the ...
Cardiology
Nov 08, 2012 |
not rated yet |
0
